EP3601533
AÐFERÐIR VIÐ FRAMLEIÐSLU ÆXLISÍFARANDI EITILFRUMNA OG NOTKUN ÞEIRRA Í ÓNÆMISMEÐFERÐ
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.1.2018EP published:
24.2.2021EP application number:
18709132.7
EP translation filed:
29.4.2021Grant published:
15.5.2021EPO information:
European Patent Register
Max expiry date:
4.1.2038Expiry date:
4.1.2027Next due date:
31.1.2027
Title:
PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
Timeline
Today
5.1.2018EP application
24.2.2021EP Publication
29.4.2021Translation submitted
15.5.2021Registration published
4.1.2027Expires
Owner
Name:
Iovance Biotherapeutics, Inc.Address:
999 Skyway Road Suite 150, San Carlos, CA 94070, US
Inventor
Name:
WARDELL, SethAddress:
Tampa, FL 33620, US
Name:
BENDER, JamesAddress:
Rancho Santa Margarita, CA 92688, US
Name:
LOTZE, Michael, T.Address:
Pittsburgh, PA 15232, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762478506 PDate:
29.3.2017Country:
US
Number:
201762539410 PDate:
31.7.2017Country:
US
Number:
201762548306 PDate:
21.8.2017Country:
US
Number:
201762554538 PDate:
5.9.2017Country:
US
Number:
201762559374 PDate:
15.9.2017Country:
US
Number:
201762567121 PDate:
2.10.2017Country:
US
Number:
201762577655 PDate:
26.10.2017Country:
US
Number:
201762582874 PDate:
7.11.2017Country:
US
Number:
201762596374 PDate:
8.12.2017Country:
US
Classification
Categories:
C12N 5/0783, C12M 1/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 20.12.2021
Expires: 4.1.2023
Payer: Patice ehf.
Number: 6
Paid: 30.12.2022
Expires: 4.1.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 4.1.2024
Expires: 4.1.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 27.12.2024
Expires: 4.1.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.1.2026
Expires: 4.1.2027
Payer: Árnason Faktor ehf.